BioSpace News Archive

Nuvo Pharmaceuticals Inc. announced the filing of the Business Acquisition Report on SEDAR related to the previously announced acquisition of a portfolio of more than 20 revenue-generating products, as well as the associated personnel and infrastructure to continue the products’ management and growth from Aralez Pharmaceuticals Inc. that closed on December 31, 2018.

4th Quarter Revenue of $1,361 Million, an increase of 18%, Net (Loss) Income Attributable to Diplomat of $(298.0) Million, compared to $6.5 Million, Adjusted EBITDA of $43.5 Million, an increase of 63%

Archer Daniels Midland Company (NYSE: ADM) announced today that it has reached an agreement to acquire the Ziegler Group, a leading European provider of natural citrus flavor ingredients.

VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”) today announced that its Chief Executive Officer, Mr. Cameron Reynolds, is scheduled to present at two conferences in the U.S. next week.

Susan G. Komen®, the world’s largest breast cancer nonprofit, has selected RKD Group as their marketing and fundraising engagement partner to support their mission to end breast cancer.

Michael Barr, CEO of Bridgeway Institute, located in Somerset, Kentucky, is proud to announce an alliance between Bridgeway and Rex Chapman, Mr. Kentucky Basketball, to jointly reach out to attack the addiction problem in Kentucky and surrounding states

According to Coherent Market Insights, the Typhoid fever vaccines market was valued at US$ 225.0 million in 2018, and is projected to exhibit a CAGR of 11.9% over the forecast period (2018–2026).

Etactics, an Ohio-based medical insurance claim clearinghouse innovator, announced their new partnership with Platinum System, a leading EHR software for Chiropractors.

Amplicare, a leading software automation provider for pharmacies, and Ananda Professional, the leading hemp-derived CBD manufacturer exclusively serving independent pharmacies, are excited to announce a partnership to expand pharmacy access to CBD and wellness education through automation software.

Actelion Pharmaceuticals US, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today an interim analysis from the Right vEntricular Remodeling in Pulmonary ArterIal hypeRtension (REPAIR) study of OPSUMIT®